[Video] Thermage Buys Reliant for $95 Million

Some older news, in video form, care of our team at OneMedPlace TV. Thermage announced it would acquire Reliant Technologies earlier this month. The stock and cash transaction was valued at ≈ $95 million and combines respective leaders in skin tightening and skin resurfacing, two fast-growing segments...

[Video Profile] Interview with Dr. Anand Lalaji, President & CEO of The Radiology Group

The Radiology Group has developed a virtual, full-service radiology department with a complete range of specialty interpretations. The company aims to match the appropriate physician with the appropriate exam in an effort to raise the standards of health care imaging while lowering costs. Services include...

NeuroMetrix Cost Cutting and Product Introductions Not Enough to Appease Investors

NeuroMetrix continues to get hammered by investors who have left the company for dead. In May, NeuroMetrix laid off 15% of its work force. The direct sales team was cut from 54 to 34 individuals. Steps were taken to reduce operating expenses by nearly $5.0 million annually in the face of declining...

Cynosure Q2: Continued Growth and Profitability

Quarterly revenues at Cynosure, a developer of laser-based aesthetic systems, grew 30% year-over-year, from $30.1 million in Q2 2007 to $39.2 million in the most recent quarter. The results were in line with the Street’s expectations. Analysts predicted revenues of $38.48 million, according to Reuters...

Cepheid: Q2 Revenues Up 55 Percent, Loss Widens

On Thursday, Cepheid reported $42.1 million in quarterly revenues, a 55% jump from the $27.2 million reported in the same period last year. Growth has been driven by hospitals intent on countering the growing scourge of healthcare associated infections (HAI). Sales of Cepheid’s Xpert MRSA test (FDA...

AngioDynamics Reports Better Than Expected Quarterly Profit

Regular readers will know I’m bullish on AngioDynamics. Yesterday, the Queensbury NY-based company reported better than expected quarterly profit, buoyed by strong sales in its interventional product line. The news sent shares soaring 15% to $16-plus. AngioDynamics’ stock had traded as low as $10 in...

[Video] New Developments at Chembio Diagnostics

Chembio Diagnostics develops, manufactures and markets rapid, point-of-care tests for the detection of HIV 1/ 2, Chagas and Sickle Cell disease as well as other human and veterinary infectious diseases, including tuberculosis (TB). Many of the company’s current products are based upon single path lateral...

Tattoo Regret Could be a Boon for Device Manufacturers

I’ll never get a tattoo. Call me conservative, but the thought of having an ink-based design etched permanently into my skin is more than the old man in me can tolerate. My geriatric attitude is just that. Among 25-29 year-olds, 36 percent of individuals have one or more tattoos, says a Harris Interactive...